ANDREWS DEBORAH J 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-01+75,000→ 75,000 totalExercise: $0.95Exp: 2034-07-01→ Common Shares (75,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer.